OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET
Rhea-AI Summary
OptimizeRx (Nasdaq: OPRX) will hold a third quarter 2025 conference call on Thursday, November 6, 2025 at 4:30 p.m. ET to discuss results for the quarter ended September 30, 2025. Management will host the call, followed by Q&A. Financial results will be released in a press release prior to the call.
Call access includes toll-free and international numbers, a Call Me link and a live webcast; a replay will be available for 12 months on the company investor website.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, OPRX gained 3.84%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
WALTHAM, Mass., Oct. 20, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, will hold a conference call on Thursday, November 6, 2025, at 4:30 p.m. Eastern Time to discuss its results for the third quarter period ended September 30, 2025. The financial results will be issued in a press release prior to the call.
OptimizeRx management will host the call, followed by a question-and-answer period. Details for the conference call can be found below:
| Date: | Thursday, November 6, 2025 |
| Time: | 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) |
| Toll Free: | 1-844-825-9789 |
| International: | 1-412-317-5180 |
| Conference ID: | 10203796 |
| Call me™ Link: | https://callme.viavid.com/?$Y2FsbG1lPXRydWUmcGFzc2NvZGU9JmluZm89Y29tcGFueSZyPXRydWUmYj0xNg== |
| Call me™ Passcode: | 1758869 |
| Webcast: | https://viavid.webcasts.com/starthere.jsp?ei=1738663&tp_key=cbe79a5b8d |
Please call the conference telephone number or log on to the web access link five minutes prior to the start time.
A replay of the call will remain available for 12 months via the Investors section of the OptimizeRx website at http://www.optimizerx.com/investors.
About OptimizeRx
OptimizeRx is a leading healthcare technology company that’s redefining how life science brands connect with patients and healthcare providers. Our platform combines innovative AI-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. By bridging the gap between HCP and DTC strategies, we empower brands to create synchronized marketing solutions that drive faster treatment decisions and improved patient outcomes.
Our commitment to privacy-safe, patient-centric technology ensures that every interaction is designed to make a meaningful impact, delivering life-changing therapies to the right patients at the right time. Headquartered in Waltham, Massachusetts, OptimizeRx partners with some of the world’s leading pharmaceutical and life sciences companies to transform the healthcare landscape and create a healthier future for all.
For more information, follow the Company on X, LinkedIn or visit www.optimizerx.com.
OptimizeRx Contact
Andy D’Silva, Chief Business Officer
adsilva@optimizerx.com
Investor Relations Contact
Steven Halper
LifeSci Advisors, LLC
shalper@lifesciadvisors.com
FAQ
When is OptimizeRx's OPRX third quarter 2025 conference call scheduled?
How can investors listen to the OptimizeRx (OPRX) Q3 2025 earnings call?
Will OptimizeRx release financial results before the November 6, 2025 call?
Is there a replay of the OptimizeRx OPRX Q3 2025 call and where is it available?
What is the conference ID and passcode for the OptimizeRx November 6, 2025 call?
What time is the OptimizeRx call in Pacific Time on November 6, 2025?
